Wednesday, August 20, 2014 4:27:02 PM
NOTE 6– INTELLECTUAL PROPERTY RIGHTS
Therapy Cells Inc announced in 2013 that on12 February 2013, US patent
8,372,644 was awarded Dr P Casey, et al. The Assignee
under that patent number is Transplantation Ltd, a company registered in New Zealand. Transplantation Ltd has
exclusively
invested in Therapy Cells Inc a licence for the use of the process for equine and human applications. Due to funding constraints
we have been unable to progress the approval process from the US Food and Drug Administration (FDA) for human applications.
Our funding activity has increased significantly over the last quarter and we are close to finalising a long-term funding
arrangemet that will allow us to fast-track the FDA process
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM